HSR26-217: Refining Surgical Eligibility in Cirrhotic Hepatocellular Carcinoma: A Propensity-Matched TriNetX Analysis
Journal of the National Comprehensive Cancer Network · 31.03.2026 · 24 (3.5)
DOI: 10.6004/jnccn.2025.7218 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, erschienen am 31.03.2026. Verfasst von Aqsa Zoey Sorathia und 2 weiteren Autor:innen. Beteiligte Einrichtung: 1Resident Physician, Department of Internal Medicine, St. Joseph's University Medical Center, Paterson, NJ.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- 1Resident Physician, Department of Internal Medicine, St. Joseph's University Medical Center, Paterson, NJ.
- 2Medical Graduate, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.
Zitieren
APA
Sorathia, A. Z., Rajab, I. M., & Zahran, A. (2026). HSR26-217: Refining Surgical Eligibility in Cirrhotic Hepatocellular Carcinoma: A Propensity-Matched TriNetX Analysis. Journal of the National Comprehensive Cancer Network, 24(3.5). https://doi.org/10.6004/jnccn.2025.7218
Vancouver
Sorathia AZ, Rajab IM, Zahran A. HSR26-217: Refining Surgical Eligibility in Cirrhotic Hepatocellular Carcinoma: A Propensity-Matched TriNetX Analysis. Journal of the National Comprehensive Cancer Network. 2026;24(3.5). doi:10.6004/jnccn.2025.7218
BibTeX
@article{Sorathia2026,
author = {Sorathia, Aqsa Zoey and Rajab, Islam M and Zahran, Anwar},
title = {HSR26-217: Refining Surgical Eligibility in Cirrhotic Hepatocellular Carcinoma: A Propensity-Matched TriNetX Analysis},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2026},
volume = {24},
number = {3.5},
doi = {10.6004/jnccn.2025.7218}
}
EUVIMED